The Chrysalis Capital is a Lagos-based venture capital firm founded in 2019 that invests in early-stage technology companies across Africa and the diaspora. It operates under The Chrysalis Company and manages a $15 million fund targeting sectors including fintech, e-commerce, blockchain, healthcare, and renewable energy.
33% of their portfolio is in Healthcare. Average disclosed round size is $28.9M (across 7 rounds with reported amounts).
Portfolio
8
Fund Size
$15M
Top Stage
Series A
Last 12 Mo
0
Team
NY
Nichole Yembra
Managing Partner
AA
Adedayo Adeoye
Finance and Investment Analyst
EO
Elton Oshodipe
Senior Analyst
RA
Rosemary Allwell
Finance and Investment Analyst
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Smart | Series E | — | Mar 2024 |
| Smart | Series E | $95M | May 2023 |
 BehaVR | Series B | $13M | Dec 2022 |
 Bitmama | Pre-Seed | $2M | Sep 2022 |
 Regent Education | Growth | — | Jun 2022 |
 Bamboo | Series A | $15M | Jan 2022 |
 Votive Health | Seed | $2.5M | Apr 2021 |
 StraighterLine | Series A | $10M | Apr 2012 |
 Vesta Healthcare | Series C | $65M | — |
Top Co-Investors
Fidelity Investments2 shared
Passion Capital1 shared
Y Combinator1 shared
Saison Capital1 shared
Motley Fool Ventures1 shared
Tiger Global Management, LLC1 shared
Greycroft1 shared
Aquiline Capital Partners1 shared
Barclays1 shared
Launch Africa Ventures1 shared
Adaverse1 shared
Flourish Ventures1 shared
Greenoaks Capital1 shared
Five35 Ventures1 shared
New Markets Venture Partners1 shared
Oxford Science Enterprises1 shared
Optum Ventures1 shared
Accenture1 shared
City Light Capital1 shared
FirstMark Capital1 shared
Last updated: 8 September 2026